Cargando…

Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect

Acute graft-versus-host disease (GvHD) causes significant mortality in patients undergoing allogeneic hematopoietic cell transplantation. Immunosuppressive treatment for GvHD can impair the beneficial graft-versus-leukemia effect and facilitate malignancy relapse. Therefore, novel approaches that pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Haring, Eileen, Uhl, Franziska M., Andrieux, Geoffroy, Proietti, Michele, Bulashevska, Alla, Sauer, Barbara, Braun, Lukas M., de Vega Gomez, Enrique, Esser, Philipp R., Martin, Stefan F., Pfeifer, Dietmar, Follo, Marie, Schmitt-Graeff, Annette, Buescher, Joerg, Duyster, Justus, Grimbacher, Bodo, Boerries, Melanie, Pearce, Erika L., Zeiser, Robert, Apostolova, Petya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327708/
https://www.ncbi.nlm.nih.gov/pubmed/32675222
http://dx.doi.org/10.3324/haematol.2019.242990
_version_ 1783732148932444160
author Haring, Eileen
Uhl, Franziska M.
Andrieux, Geoffroy
Proietti, Michele
Bulashevska, Alla
Sauer, Barbara
Braun, Lukas M.
de Vega Gomez, Enrique
Esser, Philipp R.
Martin, Stefan F.
Pfeifer, Dietmar
Follo, Marie
Schmitt-Graeff, Annette
Buescher, Joerg
Duyster, Justus
Grimbacher, Bodo
Boerries, Melanie
Pearce, Erika L.
Zeiser, Robert
Apostolova, Petya
author_facet Haring, Eileen
Uhl, Franziska M.
Andrieux, Geoffroy
Proietti, Michele
Bulashevska, Alla
Sauer, Barbara
Braun, Lukas M.
de Vega Gomez, Enrique
Esser, Philipp R.
Martin, Stefan F.
Pfeifer, Dietmar
Follo, Marie
Schmitt-Graeff, Annette
Buescher, Joerg
Duyster, Justus
Grimbacher, Bodo
Boerries, Melanie
Pearce, Erika L.
Zeiser, Robert
Apostolova, Petya
author_sort Haring, Eileen
collection PubMed
description Acute graft-versus-host disease (GvHD) causes significant mortality in patients undergoing allogeneic hematopoietic cell transplantation. Immunosuppressive treatment for GvHD can impair the beneficial graft-versus-leukemia effect and facilitate malignancy relapse. Therefore, novel approaches that protect and regenerate injured tissues without impeding the donor immune system are needed. Bile acids regulate multiple cellular processes and are in close contact with the intestinal epithelium, a major target of acute GvHD. Here, we found that the bile acid pool is reduced following GvHD induction in a preclinical model. We evaluated the efficacy of bile acids to protect the intestinal epithelium without reducing anti-tumor immunity. We observed that application of bile acids decreased cytokine-induced cell death in intestinal organoids and cell lines. Systemic prophylactic administration of tauroursodeoxycholic acid (TUDCA), the most potent compound in our in vitro studies, reduced GvHD severity in three different murine transplantation models. This effect was mediated by decreased activity of the antigen presentation machinery and subsequent prevention of apoptosis of the intestinal epithelium. Moreover, bile acid administration did not alter the bacterial composition in the intestine suggesting that its effects are cell-specific and independent of the microbiome. Treatment of human and murine leukemic cell lines with TUDCA did not interfere with the expression of antigen presentation-related molecules. Systemic T-cell expansion and especially their cytotoxic capacity against leukemic cells remained intact. This study establishes a role for bile acids in the prevention of acute GvHD without impairing the graft-versus-leukemia effect. In particular, we provide a scientific rationale for the systematic use of TUDCA in patients undergoing allogeneic hematopoietic cell transplantation.
format Online
Article
Text
id pubmed-8327708
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-83277082021-08-11 Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect Haring, Eileen Uhl, Franziska M. Andrieux, Geoffroy Proietti, Michele Bulashevska, Alla Sauer, Barbara Braun, Lukas M. de Vega Gomez, Enrique Esser, Philipp R. Martin, Stefan F. Pfeifer, Dietmar Follo, Marie Schmitt-Graeff, Annette Buescher, Joerg Duyster, Justus Grimbacher, Bodo Boerries, Melanie Pearce, Erika L. Zeiser, Robert Apostolova, Petya Haematologica Article Acute graft-versus-host disease (GvHD) causes significant mortality in patients undergoing allogeneic hematopoietic cell transplantation. Immunosuppressive treatment for GvHD can impair the beneficial graft-versus-leukemia effect and facilitate malignancy relapse. Therefore, novel approaches that protect and regenerate injured tissues without impeding the donor immune system are needed. Bile acids regulate multiple cellular processes and are in close contact with the intestinal epithelium, a major target of acute GvHD. Here, we found that the bile acid pool is reduced following GvHD induction in a preclinical model. We evaluated the efficacy of bile acids to protect the intestinal epithelium without reducing anti-tumor immunity. We observed that application of bile acids decreased cytokine-induced cell death in intestinal organoids and cell lines. Systemic prophylactic administration of tauroursodeoxycholic acid (TUDCA), the most potent compound in our in vitro studies, reduced GvHD severity in three different murine transplantation models. This effect was mediated by decreased activity of the antigen presentation machinery and subsequent prevention of apoptosis of the intestinal epithelium. Moreover, bile acid administration did not alter the bacterial composition in the intestine suggesting that its effects are cell-specific and independent of the microbiome. Treatment of human and murine leukemic cell lines with TUDCA did not interfere with the expression of antigen presentation-related molecules. Systemic T-cell expansion and especially their cytotoxic capacity against leukemic cells remained intact. This study establishes a role for bile acids in the prevention of acute GvHD without impairing the graft-versus-leukemia effect. In particular, we provide a scientific rationale for the systematic use of TUDCA in patients undergoing allogeneic hematopoietic cell transplantation. Fondazione Ferrata Storti 2020-07-16 /pmc/articles/PMC8327708/ /pubmed/32675222 http://dx.doi.org/10.3324/haematol.2019.242990 Text en Copyright© 2021 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Article
Haring, Eileen
Uhl, Franziska M.
Andrieux, Geoffroy
Proietti, Michele
Bulashevska, Alla
Sauer, Barbara
Braun, Lukas M.
de Vega Gomez, Enrique
Esser, Philipp R.
Martin, Stefan F.
Pfeifer, Dietmar
Follo, Marie
Schmitt-Graeff, Annette
Buescher, Joerg
Duyster, Justus
Grimbacher, Bodo
Boerries, Melanie
Pearce, Erika L.
Zeiser, Robert
Apostolova, Petya
Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect
title Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect
title_full Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect
title_fullStr Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect
title_full_unstemmed Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect
title_short Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect
title_sort bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327708/
https://www.ncbi.nlm.nih.gov/pubmed/32675222
http://dx.doi.org/10.3324/haematol.2019.242990
work_keys_str_mv AT haringeileen bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect
AT uhlfranziskam bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect
AT andrieuxgeoffroy bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect
AT proiettimichele bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect
AT bulashevskaalla bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect
AT sauerbarbara bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect
AT braunlukasm bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect
AT devegagomezenrique bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect
AT esserphilippr bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect
AT martinstefanf bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect
AT pfeiferdietmar bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect
AT follomarie bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect
AT schmittgraeffannette bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect
AT buescherjoerg bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect
AT duysterjustus bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect
AT grimbacherbodo bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect
AT boerriesmelanie bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect
AT pearceerikal bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect
AT zeiserrobert bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect
AT apostolovapetya bileacidsregulateintestinalantigenpresentationandreducegraftversushostdiseasewithoutimpairingthegraftversusleukemiaeffect